CREDIT AGREEMENT Dated as of April 27, 2016 among RELYPSA, INC., as the Borrower, CERTAIN DOMESTIC SUBSIDIARIES OF THE BORROWER, as the Guarantors, CANTOR FITZGERALD SECURITIES, as the Administrative Agent and THE LENDERS FROM TIME TO TIME PARTY HERETOCredit Agreement • August 4th, 2016 • Relypsa Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of April 27, 2016 among RELYPSA, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and CANTOR FITZGERALD SECURITIES, as Administrative Agent.
SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASESettlement Agreement • August 4th, 2016 • Relypsa Inc • Pharmaceutical preparations • Delaware
This Settlement Agreement and Mutual General Release (this "Agreement") is made and entered into as of June 21, 2016 (the “Effective Date”), by and among Relypsa, Inc., a Delaware corporation, with its principal office located at 100 Cardinal Way, Redwood City, CA 94063 ("Relypsa") and LANXESS Corporation, a Delaware corporation, with its principal office located at 111 RIDC Park West Drive, Pittsburgh, PA 15275 ("Lanxess").
Amendment No. 1 to Manufacturing and Supply Agreement between Lanxess Corporation and Relypsa, Inc.Manufacturing and Supply Agreement • August 4th, 2016 • Relypsa Inc • Pharmaceutical preparations
This Amendment No. 1 to the Manufacturing and Supply Agreement (“Amendment No. 1”) is made and entered into effective as of June 21, 2016 (the “Amendment No. 1 Effective Date”) by and between Relypsa, Inc., a Delaware corporation, located at 100 Cardinal Way, Redwood City, CA 94063 (“Relypsa”) and Lanxess Corporation, a Delaware corporation, with an address at 111 RIDC Park West Drive, Pittsburgh, PA 15275 (“Lanxess”).
